Dopavision, a company pioneering the development of digital therapeutics, today announced the closing of a €12 million Series A financing round. Seventure Partners led the round and was joined by Novartis Pharmaceuticals and the Company´s existing shareholders such as Boehringer Ingelheim Venture Fund and Ababax Health, significantly broadening the Company’s shareholder base of leading international […]